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INTRODUCTION
Mineralocorticoid receptor (MR) was originally
thought to be activated by aldosterone and to act
primarily by promoting sodium retention and po-
tassium excretion in the kidney, thereby elevating
blood pressure. MR is located in the cytosol of tar-
get cells and the aldosterone-MR complex is then
translocated to the cell nucleus, to modulate gene
expression and translation of specific aldosterone-
induced proteins that regulate electrolyte and fluid
balance. Arriza et al. successfully cloned MR in
1987, identifying the receptor for aldosterone (1).
MR is also known to be distributed not only in the
kidney, but also in the cardiovascular and central
nervous systems (2).
During the last 15 years, the direct role of the
MR in contributing to cardiovascular diseases has
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become clear. Two clinical studies, Randomized Al-
dactone Evaluation Study (RALES) (3) and Epleren-
one Post-Acute Myocardial Infarction Heart Fail-
ure Efficacy and Survival Study (EPHESUS) (4), in
which MR antagonists were used for heart failure
patients, have identified major therapeutic benefits
of MR antagonism in cardiac failure, emphasizing
the importance of MR activation in causing adverse
cardiovascular pathophysiological effects. In RALES,
administration of the MR antagonist spironolactone
to patients with heart failure who were already re-
ceiving treatment with an ACE inhibitor, diuretics
and digoxin reduced mortality by 30% (3). Further-
more, EPHESUS studied the effects of the selec-
tive MR antagonist eplerenone in patients with left
ventricular dysfunction following recent myocardial
infarction (4). The addition of eplerenone signifi-
cantly reduced all-cause and cardiovascular mortal-
ity. MR inactivation is thought to inhibit myocar-
dial fibrosis and preserve cardiac function. Organ
damage following MR activation has been reported
in various organs other than the heart, and these ef-
fects have been attributed to the direct role of al-
dosterone through MR-mediated mechanisms (5).
Inhibition of MR activation by an MR antagonist is
thus performed to prevent organ damage (6, 7).
MR binds mineralocorticoids and physiologic glu-
cocorticoids with equal affinity. In epithelial tissues
such as the kidney, MR is coexpressed with the
enzyme 11β -hydroxysteroid dehydrogenase type 2
(11β -HSD2), which catalyzes the conversion of ac-
tive glucocorticoids into inactive metabolites. MR
selectivity for aldosterone is thus protected by 11β -
HSD2 in epithelial tissues. In contrast, expression
of 11β -HSD2 is very low or absent in non-epithelial
tissues such as the heart, suggesting that the ma-
jority of MR are likely to be occupied by glucocor-
ticoids with very few accessible by aldosterone in
these tissues (5).
McCurley et al. summarized the role of vascular
MR in regulating normal vascular function and in
promoting vascular disease (8). They support that
MR activation promotes vascular cell oxidative stress,
inflammation, proliferation, migration and extracellu-
lar matrix production, thereby promoting vasocon-
striction, atherosclerosis, vascular remodeling and
fibrosis (Scheme. 1).
The present study examined the presence of MR
and 11β -HSD2 in the human penile corpus caver-
nosum. If MR is also present in the human penile
Scheme 1. Mineralocorticoid receptor in vascular function and disease. (Adapted from McCurley’s review.)
McCurley et al. reveal the mechanism that MR activation promotes vascular dysfunction and disease (8).
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corpus cavernosum, human penis appears to be an
aldosterone-responsive tissue. Therefore, MR an-
tagonism may be therapeutically beneficial in the
human penile corpus cavernosum, as MR block-
ade prevents organ damage in the cardiovascular
system.
MATERIALS AND METHODS
This study was performed with the approval of
an institutional review board at the University of
Tokushima Graduate School and complied with the
tenets of the Declaration of Helsinki.
Subjects
Normal tissues from human penile corpus caver-
nosum and human renal parenchyma were obtained
surgically. Renal tubules, which are known to pos-
sess both MR and 11β -HSD2, were used as posi-
tive controls. Penile tissue samples were obtained
from 2 patients with penile cancer and 3 patients
with bladder cancer. Median age of these patients
was 62 years (range 55 to 77). Meanwhile renal
tissue samples were obtained from 5 patients with
renal tumor. Median age of these patients was 46
years (range 35 to 54). After harvesting, tissue sam-
ples for RNA extraction were immediately immersed
in RNA stabilization solution (RNAlater ; Applied
Biosystems, Foster City, CA, USA) to inhibit the
destruction of RNA, and were then stored at 4.
At the same time, tissue samples for immunofluo-
rescence assay were fixed in embedding medium
(Tissue-Tek OCT compound ; Sakura Finetechnical,
Tokyo, Japan) and frozen for preservation at -80.
Quantitative real-time reverse transcription polym-
erase chain reaction (RT-PCR) assay
Total RNA was isolated from human penile tissues
using commercial RNeasy kits (Qiagen, Valencia,
CA, USA). Complementary DNA was synthesized
from 1 μg of total RNA using a QuantiTect Reverse
Transcription kit (Qiagen). QuantiTect Primer Assay
QT00028490 (Qiagen) was used as the PCR primer
for MR. The PCR primer for 11β -HSD2 was de-
signed according to Slight et al. (9) ; the sense
primer was 5’ -GACCAAACCAGGAGACATTAGC-
3’ (525-546) ; and the antisense primer was 5’ -
ATCTAGTCCTTGCCGTAGGC-3’ (987-1007). The
real-time PCR procedure was performed using a
QuantiTect SYBR Green PCR kit (Qiagen), with
human renal parenchyma as a positive control for
MR and 11β -HSD2. For relative quantification, we
used glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) with the primer from QuantiTect Primer
Assay QT00079247 (Qiagen). PCR was performed
using the LightCycler version 3.5 Real-Time PCR
System (Roche, Basel, Switzerland).
Immunofluorescence analysis
Frozen samples were cut into 5-μm sections,
fixed in 4% paraformaldehyde for 10 min, then
washed 3 times with phosphate-buffered saline for
5 min each and incubated with 10% normal goat se-
rum for 30 min at room temperature. Expression
of MR and 11β -HSD2 was analyzed using a mouse
monoclonal antibody H10E4C9F (ab2774 ; Abcam,
Cambridge, UK) and an affinity-purified goat poly-
clonal antibody 11β -HSD2(T-12) (sc-19262 ; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), respec-
tively. Sections were incubated with anti-MR anti-
body at a dilution of 1 : 200. Rabbit polyclonal anti-
body against smooth muscle actin (RB-9010-R7 ;
Thermo Fisher Scientific, Fremont, CA, USA) was
used for detecting smooth muscle cells. This anti-
body was ready-to-use for immunohistochemical
staining. For immunofluorescence assays, anti-MR
antibody and anti-actin antibody complexes were
visualized with goat anti-mouse immunoglobulin
(Ig)G (AlexaFluor568 ; Invitrogen, Carlsbad, CA,
USA) and goat anti-rabbit IgG (AlexaFluor488 ; In-
vitrogen), respectively. We performed counterstain-
ing using 4’ -6-diamidino-2-phenylindole (DAPI).
AlexaFluor568 staining, AlexaFluor488 staining and
counterstaining with DAPI appeared as red, green
and blue, respectively. On other sections, the 11β -
HSD2-antibody complex was visualized using don-
key anti - goat IgG (AlexaFluor568 ; Invitrogen).
Staining for actin and cell nuclei was performed in
the same way. Sections were examined under a fluo-
rescence microscope. Renal parenchyma was used
as a positive control, while samples incubated with
secondary antibody alone were used as negative
controls.
RESULTS
MR mRNA expression was confirmed by RT-PCR
analysis of human penile corpus cavernosum and
human renal parenchyma. Relative quantification
of MR was performed in penile tissues (Table 1)
and in renal tissues (Table 2), normalizing against
GAPDH expression. Mean MR/GAPDH ratios of
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human penile corpus cavernosum and renal paren-
chyma were 4.05 and 20.6, respectively. On quanti-
tative RT-PCR analysis, 11β-HSD2 mRNA expres-
sion was minimal in penile tissue (Table 1) when
compared to renal tissues (Table 2) ; mean 11β-
HSD2/GAPDH ratios in human penile corpus cav-
ernosum and renal parenchyma were 0.0128 and
28.3, respectively.
Immunofluorescence analyses revealed positive
staining for MR in penile tissues (Fig. 1a). MR was
also expressed on renal tubular and renal small ar-
teries. In penile tissues, MR-positive regions over-
lapped corpus cavernosum smooth muscle cells
(Fig. 1a-1d). On the other hand, although positive
staining for 11β -HSD2 was confirmed in renal tis-
sues, negative staining for 11β -HSD2 was confirmed
in penile tissues.
Table 1. Quantitative real - time RT-PCR results for human
penile tissue
Sample MR/GAPDH 11β -HSD2/GAPDH
P-1 4.15 0.0341
P-2 4.21 0.0197
P-3 2.62 0.00284
P-4 3.95 0.00134
P-5 5.30 0.00604
MeanSD 4.050.96 0.01280.0139
SD, standard deviation
Table 2. Quantitative real - time RT-PCR results for human
renal tissue.
Sample MR/GAPDH 11β -HSD2/GAPDH
R-1 19.0 48.1
R-2 28.7 23.3
R-3 9.07 9.70
R-4 19.4 48.5
R-5 26.8 11.7
MeanSD 20.67.76 28.319.0
SD, standard deviation
(a) (b)
(c) (d)
Figure 1. Immunofluorescence staining of human penile corpus cavernosum.
a) MR is stained red by AlexaFluor568 secondary antibody.
b) Smooth muscle cells are stained green by AlexaFluor488 secondary antibody.
c) Counterstaining with DAPI is seen in blue.
d) Triple staining : MR-positive areas overlap with corpus cavernosum smooth muscle cells.
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DISCUSSION
We examined whether MR and 11β -HSD2 are
expressed in the human corpus cavernosum. MR
mRNA expression was confirmed in corpus caver-
nosum tissue, although levels of expression were
lower than those found in renal tissue. Immunostain-
ing showed that MR exists in smooth muscle cells
of the corpus cavernosum. Moreover, 11β-HSD2
mRNA expression was extremely low in the corpus
cavernosum tissue and the results of immunostain-
ing were negative. Our study thus demonstrated
that MR is relatively rich and 11β -HSD2 is essen-
tially absent in human penile corpus cavernosum.
These results are similar to the patterns seen in
non-epithelial tissues, such as the heart and brain.
An association has been observed between in-
creased severity of erectile dysfunction (ED) and
decreased smooth muscle content (10). MR activa-
tion may cause tissue damage in the corpus caver-
nosum because of MR expression in the human
penile corpus cavernosum. If this is true, MR block-
ade to prevent damage to cavernosal tissues would
thus contribute to the prevention and treatment of
ED.
Fogari et al. presented evidence that angiotensin
II receptor blockers have positive effects on male
sexuality (11). In a randomized double-blind cross-
over study of untreated hypertensive men, they com-
pared effects of the angiotensin II receptor blocker
valsartan and the β -blocker carvedilol on sexual ac-
tivity. That study showed that valsartan led to a sig-
nificant increase in sexual activity when compared
with carvedilol. Düsing also suggested that valsar-
tan improved sexual function in hypertensive males
(12). Toblli et al. reported that male spontaneous
hypertensive rats being given the angiotensin recep-
tor blocker candesartan or the β -blocker Atenolol
showed similar control in blood pressure, but can-
desartan provided a significant protective role against
cavernosum tissue compared with atenolol (13).
They suggested that candesartan prevented caver-
nosum tissue fibrosis, but the mechanism has not
been clarified. MR inactivation associated with sup-
pression of the renin-angiotensin-aldosterone sys-
tem by angiotensin receptor blocker may be in-
volved in the positive effects on sexual function
and protection of corpus cavernosum tissues.
In humans, 11β -HSD2 catalyzes the conversion of
cortisol, which is capable of binding to MR with high
affinity, into cortisone, which is incapable of bind-
ing MR. The action of 11β -HSD2 thus effectively
protects MR from occupation by cortisol. In the
heart, expression of 11β-HSD2 is very low and cardi-
omyocyte MR are normally occupied (but not acti-
vated) by cortisol. As little 11β -HSD2 is present in
the human penile corpus cavernosum, most MR are
likely to be occupied by cortisol. Qin et al. reported
that transgenic mice overexpressing 11β -HSD2 in
cardiomyocytes developed cardiac hypertrophy, fibro-
sis and heart failure in the absence of hypertension,
and that eplerenone treatment reversed these effects
(14). These studies suggested a protective role for
glucocorticoids in preventing the harmful actions of
aldosterone. However, Mihailidou et al. have shown
that cardiac damage is aggravated by MR activation
induced by cortisol below myocardial ischemia-
reperfusion (15). They mentioned that changes in
redox state during oxidative stress may drive car-
diomyocyte and vascular smooth muscle cell MR
activation by glucocorticoids. We suppose that MR-
mediated effects of cortisol in the corpus caverno-
sum smooth muscle cells are similar to those in the
cardiomyocytes.
The rapid effects of aldosterone on human penile
corpus cavernosum were investigated by Muguruma
et al. (16). They demonstrated that aldosterone ex-
erts no direct contractile or relaxation activity on hu-
man penile cavernosum tissue, but acts to signifi-
cantly enhance noradrenaline-induced contraction.
This effect was suppressed by the addition of spiro-
nolactone, supporting the presence of MR in human
penile corpus cavernosum.
Caprio et al. recently suggested the potential
benefits of selective MR antagonism in the treat-
ment of ED (17). In their opinion, endothelial dam-
age caused by an excess of MR activation may in-
duce ED. Additionally, we consider that MR activa-
tion has direct negative impacts on the corpus cav-
ernosum similar to the effects on cardiomyocytes
and vascular smooth muscle cells. Further explo-
ration is required to confirm this hypothesis.
This study demonstrated the presence of MR and
the absence of 11β -HSD2 in human penile corpus
cavernosum. Considering that MR antagonism pre-
vents various organ damages, we may hope for simi-
lar outcomes in the human penile corpus caverno-
sum. Therefore, investigations for the penile effects
of MR activation have the potential to provide new
treatment approaches for erectile dysfunction.
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